OtherAnti-HIVPositive observation
Record detail Figure 5B; Table S2. VP positive control on hV1aR.
- Measure
- EC50
- Value
- Not reported
- Target
- Homo sapiens
- Assay
- Not reported by source
Primary literature evidence
Experimental evidence search
Search paper-level observations with their value, target, assay, evidence sentence, source location, and stable record links. Evidence without a safely standardized sequence remains visible without being misrepresented as a canonical peptide.
Evidence records
14 results
OtherAnti-HIVPositive observation
Record detail Figure 5C; Table S2. VP positive control on hV1bR.
- Measure
- EC50
- Value
- Not reported
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5B; Table S2. DCMAC-VP 2 on hV1aR. Text: '565 → 3300-fold higher EC50 values than parent peptides'.
- Measure
- EC50
- Value
- =2
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5C; Table S2. DCMAC-VP 2 on hV1bR. Text: '565 → 3300-fold higher EC50 values than parent peptides'.
- Measure
- EC50
- Value
- =2
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVNegative / threshold
Record detail Figure 5B; Table S2. DCANBP-VP 4 on hV1aR. Text: '>2,100-3,900-fold higher EC50 values compared to parent peptides'.
- Measure
- EC50
- Value
- >2,100
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVNegative / threshold
Record detail Figure 5C; Table S2. DCANBP-VP 4 on hV1bR. Text: '>2,100-3,900-fold higher EC50 values compared to parent peptides'.
- Measure
- EC50
- Value
- >2,100
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5B; Table S2. Me6I2-BODIPY-VP 6 on hV1aR. Text: '3- to 9-fold rightward shift in EC50 compared to VP'.
- Measure
- EC50
- Value
- =6
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5C; Table S2. Me6I2-BODIPY-VP 6 on hV1bR. Text: '3- to 9-fold rightward shift in EC50 compared to VP'.
- Measure
- EC50
- Value
- =6
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5E; Table S3. DCMAC-VP 2* on hV1aR. Text: '340-fold increase in potency for hV1aR'.
- Measure
- EC50
- Value
- =2
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5E; Table S3. DCANBP-VP 4* on hV1aR. Text: '385-fold increase in activity'.
- Measure
- EC50
- Value
- =4
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAnti-HIVPositive observation
Record detail Figure 5E; Table S3. Me6I2-BODIPY-VP 6* on hV1aR. Text: 'only a minor increase in activity (~2-fold)'.
- Measure
- EC50
- Value
- ~2
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAntibacterialNegative / threshold
Record detail Figure 5F. DCMAC-VP 2 at 100 nM on hOTR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
- Measure
- percent_inhibition
- Value
- na
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAntibacterialNegative / threshold
Record detail Figure 5F. DCANBP-VP 4 at 100 nM on hOTR. Text: 'most caged photoprobes exhibited no activity at 100 nM'.
- Measure
- percent_inhibition
- Value
- na
- Target
- Homo sapiens
- Assay
- Not reported by source
OtherAntibacterialPositive observation
Record detail Figure 5F. Me6I2-BODIPY-VP 6 at 100 nM on hOTR. Text: 'Me6I2-BODIPY-VP 6, with ~50% activation at hOTR'.
- Measure
- percent_inhibition
- Value
- ~50% activation
- Target
- Homo sapiens
- Assay
- Not reported by source
Names such as P1, PEP1, or peptide 1 are paper-local labels. Search results group them by publication and never assume cross-paper molecular identity without sequence or explicit structural evidence.